Biosecurity in pathology laboratories; COVID-19 pandemic. Narrative review
World Health Organization in its laboratory biosafety manual, classifies infectious agents into 4 risk groups ranging from level 1 to 4, these levels provide a series of procedures for the protection of laboratory personnel. After the risk assessment, SARS-CoV-2 is a pathogenic virus with a high mor...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Universidad del Zulia,Facultad de Medicina,Departamento de Enfermedades Infecciosas y Tropicales
2020-10-01
|
| Series: | Kasmera |
| Subjects: | |
| Online Access: | https://produccioncientificaluz.org/index.php/kasmera/article/view/32616 |
| _version_ | 1797727267758014464 |
|---|---|
| author | Walter Oqueli Vásquez Bonilla Héctor Silva Cárcamo |
| author_facet | Walter Oqueli Vásquez Bonilla Héctor Silva Cárcamo |
| author_sort | Walter Oqueli Vásquez Bonilla |
| collection | DOAJ |
| description | World Health Organization in its laboratory biosafety manual, classifies infectious agents into 4 risk groups ranging from level 1 to 4, these levels provide a series of procedures for the protection of laboratory personnel. After the risk assessment, SARS-CoV-2 is a pathogenic virus with a high mortality rate and a problem for public health, which has been classified in risk group level 3. Surgical pathology and cytology activities typical of pathology laboratories are carried out under a biosafety level 2, due to the classification of SARS-CoV-2 within risk group 3, it is necessary to reinforce security measures to protect personnel, these laboratories play an important role in histopathological diagnosis, providing information on the pathophysiology of the disease and the mechanisms that lead to the death of patients; which will make it possible to improve the treatment of the disease and design effective public health policies. This review describes the biosecurity measures that must be implemented in pathology laboratories during the current COVID-19 pandemic. |
| first_indexed | 2024-03-12T10:57:24Z |
| format | Article |
| id | doaj.art-4c8df9c7a64e4942a24ff9c3026659d3 |
| institution | Directory Open Access Journal |
| issn | 0075-5222 2477-9628 |
| language | English |
| last_indexed | 2024-03-12T10:57:24Z |
| publishDate | 2020-10-01 |
| publisher | Universidad del Zulia,Facultad de Medicina,Departamento de Enfermedades Infecciosas y Tropicales |
| record_format | Article |
| series | Kasmera |
| spelling | doaj.art-4c8df9c7a64e4942a24ff9c3026659d32023-09-02T06:08:25ZengUniversidad del Zulia,Facultad de Medicina,Departamento de Enfermedades Infecciosas y TropicalesKasmera0075-52222477-96282020-10-01482e48232616e4823261610.5281/zenodo.405365733648Biosecurity in pathology laboratories; COVID-19 pandemic. Narrative reviewWalter Oqueli Vásquez Bonilla0Héctor Silva Cárcamo1Hospital General San Juan de Dios. Departamento de Patología. Ciudad de Guatemala.Corporación Universitaria Minuto de Dios-UNIMINUTO, Bello-AntioquiaWorld Health Organization in its laboratory biosafety manual, classifies infectious agents into 4 risk groups ranging from level 1 to 4, these levels provide a series of procedures for the protection of laboratory personnel. After the risk assessment, SARS-CoV-2 is a pathogenic virus with a high mortality rate and a problem for public health, which has been classified in risk group level 3. Surgical pathology and cytology activities typical of pathology laboratories are carried out under a biosafety level 2, due to the classification of SARS-CoV-2 within risk group 3, it is necessary to reinforce security measures to protect personnel, these laboratories play an important role in histopathological diagnosis, providing information on the pathophysiology of the disease and the mechanisms that lead to the death of patients; which will make it possible to improve the treatment of the disease and design effective public health policies. This review describes the biosecurity measures that must be implemented in pathology laboratories during the current COVID-19 pandemic.https://produccioncientificaluz.org/index.php/kasmera/article/view/32616bioseguridad, covid-19, patología, laboratorio, sars-cov-2. |
| spellingShingle | Walter Oqueli Vásquez Bonilla Héctor Silva Cárcamo Biosecurity in pathology laboratories; COVID-19 pandemic. Narrative review Kasmera bioseguridad, covid-19, patología, laboratorio, sars-cov-2. |
| title | Biosecurity in pathology laboratories; COVID-19 pandemic. Narrative review |
| title_full | Biosecurity in pathology laboratories; COVID-19 pandemic. Narrative review |
| title_fullStr | Biosecurity in pathology laboratories; COVID-19 pandemic. Narrative review |
| title_full_unstemmed | Biosecurity in pathology laboratories; COVID-19 pandemic. Narrative review |
| title_short | Biosecurity in pathology laboratories; COVID-19 pandemic. Narrative review |
| title_sort | biosecurity in pathology laboratories covid 19 pandemic narrative review |
| topic | bioseguridad, covid-19, patología, laboratorio, sars-cov-2. |
| url | https://produccioncientificaluz.org/index.php/kasmera/article/view/32616 |
| work_keys_str_mv | AT walteroquelivasquezbonilla biosecurityinpathologylaboratoriescovid19pandemicnarrativereview AT hectorsilvacarcamo biosecurityinpathologylaboratoriescovid19pandemicnarrativereview |